SIGA Technologies
SIGA
#8720
Rank
โ‚น21.53 B
Marketcap
โ‚น300.28
Share price
-1.27%
Change (1 day)
-51.48%
Change (1 year)

Revenue for SIGA Technologies (SIGA)

Revenue in 2026 (TTM): โ‚น8.11 Billion

According to SIGA Technologies's latest financial reports the company's current revenue (TTM ) is โ‚น9.05 Billion. In 2025 the company made a revenue of โ‚น8.48 Billion a decrease over the revenue in the year 2024 that were of โ‚น11.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SIGA Technologies from 1997 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น8.11 B-4.47%
2025 โ‚น8.48 B-28.66%
2024 โ‚น11.90 B2.17%
2023 โ‚น11.64 B27.07%
2022 โ‚น9.16 B-7.87%
2021 โ‚น9.94 B8.87%
2020 โ‚น9.13 B379.22%
2019 โ‚น1.90 B-94.28%
2018 โ‚น33.35 B4158.04%
2017 โ‚น0.78 B-23.08%
2016 โ‚น1.01 B87.45%
2015 โ‚น0.54 B173.03%
2014 โ‚น0.19 B-41.64%
2013 โ‚น0.34 B-30.58%
2012 โ‚น0.49 B-27.04%
2011 โ‚น0.67 B-21.82%
2010 โ‚น0.86 B34.36%
2009 โ‚น0.64 B65.31%
2008 โ‚น0.38 B47.47%
2007 โ‚น0.26 B-18.21%
2006 โ‚น0.32 B-15.73%
2005 โ‚น0.38 B378.9%
2004 โ‚น79.65 M139.08%
2003 โ‚น33.31 M
2001 โ‚น55.94 M148.13%
2000 โ‚น22.54 M22.04%
1999 โ‚น18.47 M-13.1%
1998 โ‚น21.26 M-39.89%
1997 โ‚น35.36 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น210.88 B 2,229.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น57.57 B 535.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น83.61 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น85.51 B 844.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น62.35 B 588.66%๐Ÿ‡บ๐Ÿ‡ธ USA